Long-term administration of AMD3100, an antagonist of SDF-1/CXCR4 signaling, alters fracture repair.
Toupadakis CA; Wong A; Genetos DC; Chung DJ; Murugesh D; Anderson MJ; Loots GG; Christiansen BA; Kapatkin AS; Yellowley CE; Journal Of Orthopaedic Research: Official Publication Of The Orthopaedic Research Society, 2012, vol. 30, issue 11, p 1853, ISSN 1554527x. ISBN 1554527x.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef